Works about RILUZOLE

Results: 274

Riluzole results in improved hyperarousal symptoms in veterans with PTSD.

Published in:: Brown University Psychopharmacology Update, 2021, v. 32, n. 2, p. 3, doi. 10.1002/pu.30678
Publication type:: Article

Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 2049, doi. 10.3390/jcm12052049

By:

Fessel, Jeffrey

Publication type:

Article

Correction: Long-Term Follow-Up Before and During Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.

Published in:

2024

By:

Suppiej, Agnese;
Ceccato, Chiara;
Tzekov, Radouil;
Cermakova, Iveta;
Parmeggiani, Francesco;
Bellucci, Gianmarco;
Salvetti, Marco;
Zesiewicz, Theresa;
Ristori, Giovanni;
Romano, Silvia

Publication type:

Correction Notice

Thiamine Deficiency Increases Intrinsic Excitability of Mouse Cerebellar Purkinje Cells.

Published in:

Cerebellum, 2021, v. 20, n. 2, p. 186, doi. 10.1007/s12311-020-01202-x

By:

Bolaños-Burgos, Ivonne Carolina;
Bernal-Correa, Ana María;
Mahecha, Germán Arturo Bohórquez;
Ribeiro, Ângela Maria;
Kushmerick, Christopher

Publication type:

Article

A study on the pharmacokinetic bioequivalence of oral tablet formulations of riluzole among healthy volunteers utilizing HPLC-MS/MS.

Published in:

BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00931-1

By:

Yu, Fei;
Wang, Rui;
Wang, Keli;
Lin, BoYang;
Zhou, Xuan;
Chen, Linghong;
Ma, Li;
Liao, Zheng;
Zhang, Wanggang

Publication type:

Article

Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 1, p. 57, doi. 10.1002/cpdd.1168

By:

Wymer, James;
Apple, Stephen;
Harrison, Antoinette;
Hill, Bryan Alan

Publication type:

Article

A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 476, doi. 10.1002/cpdd.747

By:

Qureshi, Irfan;
Lovegren, Meghan;
Wirtz, Victoria;
Larouche, Richard;
Tanguay, Mario;
Anderson, Matt S.;
Hartmann, Sonja;
Coric, Vlad;
Berman, Robert M.

Publication type:

Article

2016 Annual Meeting of the American College of Clinical Pharmacology, September 25-27, 2016, Bethesda, MD.

Published in:: Clinical Pharmacology in Drug Development, 2016, v. 5, p. 3, doi. 10.1002/cpdd.292
Publication type:: Article

T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1202834

By:

Pereira Lemos, Julia;
Gonçalves Tenório, Liliane Patrícia;
Mouly, Vincent;
Butler-Browne, Gillian;
Arêas Mendes-da-Cruz, Daniella;
Savino, Wilson;
Smeriglio, Piera

Publication type:

Article

Low T-cell reactivity to TDP-43 peptides in ALS.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1193507

By:

Ramachandran, Swetha;
Grozdanov, Veselin;
Leins, Bianca;
Kandler, Katharina;
Witzel, Simon;
Mulaw, Medhanie;
Ludolph, Albert C.;
Weishaupt, Jochen H.;
Danzer, Karin M.

Publication type:

Article

Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels.

Published in:

2003

By:

Beltran-Parrazal, Luis;
Charles, Andrew

Publication type:

journal article

Dancing muscles: the value of real-time ultrasound evaluation of muscle in myositis and mimics.

Published in:

Rheumatology, 2021, v. 60, n. 8, p. e275, doi. 10.1093/rheumatology/keab088

By:

Albayda, Jemima;
Hayes, Lindsey R;
Christopher-Stine, Lisa

Publication type:

Article

Pharmacologic Management Strategies in ALS #301.

Published in:

Journal of Palliative Medicine, 2016, v. 19, n. 3, p. 335, doi. 10.1089/jpm.2015.0362

By:

Scott, Kristin;
Shannon, Robert;
Roche-Green, Alva;
Searcy, Randi;
Woolyhand, Gerard;
Meeks, Gavin;
Schuh, Michael

Publication type:

Article

Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52539-4

By:

Hollingworth, David;
Thomas, Frances;
Page, Dana A.;
Fouda, Mohamed A.;
De Castro, Raquel Lopez-Rios;
Sula, Altin;
Mykhaylyk, Vitaliy B.;
Kelly, Geoff;
Ulmschneider, Martin B.;
Ruben, Peter C.;
Wallace, B. A.

Publication type:

Article

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis.

Published in:

Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.633854

By:

Povedano Panades, Mónica;
Couratier, Philippe;
Sidle, Katie;
Sorarù, Gianni;
Tsivgoulis, Georgios;
Ludolph, Albert C.

Publication type:

Article

Partial Block by Riluzole of Muscle Sodium Channels in Myotubes from Amyotrophic Lateral Sclerosis Patients.

Published in:

Neurology Research International, 2014, p. 1, doi. 10.1155/2014/946073

By:

Deflorio, Cristina;
Onesti, Emanuela;
Lauro, Clotilde;
Tartaglia, Giorgio;
Giovannelli, Aldo;
Limatola, Cristina;
Inghilleri, Maurizio;
Grassi, Francesca

Publication type:

Article

Motor unit number estimation versus compound muscle action potential in the evaluation of motor unit loss in amyotrophic lateral sclerosis.

Published in:

Egyptian Journal of Neurology, Psychiatry & Neurosurgery, 2021, v. 57, n. 1, p. 1, doi. 10.1186/s41983-021-00301-8

By:

Ibrahem, Arwa Khalid;
Al-Mahdawi, Akram Mohammed;
Hamdan, Farqad Bader

Publication type:

Article

A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorder.

Published in:

Journal of Autism & Developmental Disorders, 2018, v. 48, n. 9, p. 3051, doi. 10.1007/s10803-018-3562-5

By:

Wink, Logan K.;
Adams, Ryan;
Horn, Paul S.;
Tessier, Charles R.;
Bantel, Andrew P.;
Hong, Michael;
Shaffer, Rebecca C.;
Pedapati, Ernest V.;
Erickson, Craig A.

Publication type:

Article

Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies.

Published in:

Journal of Autism & Developmental Disorders, 2016, v. 46, n. 3, p. 825, doi. 10.1007/s10803-015-2619-y

By:

Brondino, Natascia;
Fusar-Poli, Laura;
Panisi, Cristina;
Damiani, Stefano;
Barale, Francesco;
Politi, Pierluigi

Publication type:

Article

Assessment of Pesticide Biohazards in Neurodegenerative Diseases; Data Analysis Statistical Study.

Published in:

Indian Journal of Forensic Medicine & Toxicology, 2021, v. 15, n. 4, p. 1783, doi. 10.37506/ijfmt.v15i4.16961

By:

Merkhan, Marwan M.;
Althanoon, Zeina A.;
Mohammed, Ahmed A.;
Faisal, Ibrahim M.

Publication type:

Article

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.

Published in:

Pigment Cell & Melanoma Research, 2018, v. 31, n. 4, p. 534, doi. 10.1111/pcmr.12694

By:

Mehnert, Janice M.;
Silk, Ann W.;
Lee, J. H.;
Dudek, Liesel;
Jeong, Byeong‐Seon;
Li, Jiadong;
Schenkel, Jason M.;
Sadimin, Evita;
Kane, Michael;
Lin, Hongxia;
Shih, Weichung J.;
Zloza, Andrew;
Chen, Suzie;
Goydos, James S.

Publication type:

Article

Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells.

Published in:

Pigment Cell & Melanoma Research, 2015, v. 28, n. 1, p. 105, doi. 10.1111/pcmr.12327

By:

Wall, Brian A.;
Yu, Lumeng J.;
Khan, Atif;
Haffty, Bruce;
Goydos, James S.;
Chen, Suzie

Publication type:

Article

Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.

Published in:

Pigment Cell & Melanoma Research, 2014, v. 27, n. 2, p. 263, doi. 10.1111/pcmr.12207

By:

Wall, Brian A.;
Wangari ‐ Talbot, Janet;
Shin, Seung S.;
Schiff, Devora;
Sierra, Jairo;
Yu, Lumeng J.;
Khan, Atif;
Haffty, Bruce;
Goydos, James S.;
Chen, Suzie

Publication type:

Article

Cost-utility analysis of riluzole treatment compared with supportive care for patients with amyotrophic lateral sclerosis.

Published in:

Thai Journal of Pharmaceutical Sciences, 2025, v. 49, n. 1, p. 1

By:

Rattana-amonloet, Thaiphat;
Pimkrai, Ampai;
Dilokthornsakul, Piyameth;
Permsuwan, Unchalee

Publication type:

Article

Riluzole for treating spasticity in patients with chronic traumatic spinal cord injury: Study protocol in the phase ib/iib adaptive multicenter randomized controlled RILUSCI trial.

Published in:

PLoS ONE, 2023, v. 18, n. 1, p. 1, doi. 10.1371/journal.pone.0276892

By:

Cotinat, Maëva;
Boquet, Isabelle;
Ursino, Moreno;
Brocard, Cécile;
Jouve, Elisabeth;
Alberti, Corinne;
Bensoussan, Laurent;
Viton, Jean-Michel;
Brocard, Frédéric;
Blin, Olivier

Publication type:

Article

Commentary: Urinary Neopterin, a New Marker of the Neuroinflammatory Status in Amyotrophic Lateral Sclerosis.

Published in:

Frontiers in Neuroscience, 2021, v. 15, p. N.PAG, doi. 10.3389/fnins.2021.645694

By:

Espíndola, Gisele;
Scheffer, Débora da Luz;
Latini, Alexandra

Publication type:

Article

Analysis of SOD1 variants in Chinese patients with familial amyotrophic lateral sclerosis.

Published in:

QJM: An International Journal of Medicine, 2023, v. 116, n. 5, p. 365, doi. 10.1093/qjmed/hcad010

By:

Li, H;
Yuan, L;
Yang, H;
Guo, Y;
Zheng, W;
Fan, K;
Deng, S;
Gong, L;
Xu, H;
Yang, Z;
Cheng, J;
Kang, M;
Deng, H

Publication type:

Article

Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1<sup>G93A</sup> ALS mouse model.

Published in:

2022

By:

Zhang, Haoyun;
Li, Hao;
Huang, Bingkun;
Wang, Shaoye;
Gao, Ying;
Meng, Fandi;
Chen, Yanchun;
Zhou, Fenghua;
Guan, Yingjun;
Wang, Xin

Publication type:

journal article

Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.

Published in:

BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03293-3

By:

Adashek, Jacob J.;
Pandya, Chinmayi;
Maragakis, Nicholas J.;
De, Pradip;
Cohen, Philip R.;
Kato, Shumei;
Kurzrock, Razelle

Publication type:

Article

Validation of qMT and CEST MRI as Biomarkers of Response to Treatment After Lumbar Spinal Cord Injury in Rats.

Published in:

NMR in Biomedicine, 2025, v. 38, n. 4, p. 1, doi. 10.1002/nbm.70015

By:

Mu, Chaoqi;
Reed, Jamie L.;
Wang, Feng;
Yan, Xinqiang;
Lu, Ming;
Gore, John C.;
Chen, Li Min

Publication type:

Article

Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy-a randomised controlled trial.

Published in:

2021

By:

Trinh, Terry;
Park, Susanna B.;
Murray, Jenna;
Pickering, Hannah;
Lin, Cindy S.-Y.;
Martin, Andrew;
Friedlander, Michael;
Kiernan, Matthew C.;
Goldstein, David;
Krishnan, Arun V.

Publication type:

journal article

Effect of Riluzole, a Glutamate Release Inhibitor, on Synaptic Plasticity in the Intrahippocampal Aβ Rat Model of Alzheimer's Disease.

Published in:

Neurophysiology, 2019, v. 51, n. 4, p. 266, doi. 10.1007/s11062-019-09820-w

By:

Mokhtari, Z.;
Baluchnejadmojarad, T.;
Nikbakht, F.;
Fahanik-Babaei, J.;
Roghani, M.

Publication type:

Article

GEMALS: A promising therapy for amyotrophic lateral sclerosis.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 15, n. 4, p. 3203, doi. 10.3892/etm.2018.5868

By:

Geffard, Michel;
Mangas, Arturo;
Bedat, Denis;
Coveñas, Rafael

Publication type:

Article

Riluzole Reverses Blood–Testis Barrier Loss to Rescue Chemotherapy–Induced Male Infertility by Binding to TRPC.

Published in:

Cells (2073-4409), 2024, v. 13, n. 23, p. 2016, doi. 10.3390/cells13232016

By:

Huang, Rufei;
Xia, Huan;
Lin, Wanqing;
Wang, Zhaoyang;
Li, Lu;
Deng, Jingxian;
Ye, Tao;
Li, Ziyi;
Yang, Yan;
Huang, Yadong

Publication type:

Article

Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes.

Published in:

Cells (2073-4409), 2021, v. 10, n. 6, p. 1442, doi. 10.3390/cells10061442

By:

Pagliaroli, Luca;
Fothi, Abel;
Nespoli, Ester;
Liko, Istvan;
Veto, Borbala;
Devay, Piroska;
Szeri, Flora;
Hengerer, Bastian;
Barta, Csaba;
Aranyi, Tamas

Publication type:

Article

Mineralization of Riluzole by Heterogeneous Fenton Oxidation Using Natural Iron Catalysts.

Published in:

Catalysts (2073-4344), 2023, v. 13, n. 1, p. 68, doi. 10.3390/catal13010068

By:

Bensalah, Nasr;
Neily, Emna;
Bedoui, Ahmed;
Ahmad, Mohammad I.

Publication type:

Article

Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.

Published in:

Drugs, 2017, v. 77, n. 4, p. 381, doi. 10.1007/s40265-017-0702-8

By:

Lener, Marc;
Kadriu, Bashkim;
Zarate, Carlos

Publication type:

Article

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

Published in:

Drugs, 2016, v. 76, n. 7, p. 759, doi. 10.1007/s40265-016-0566-3

By:

Vijayakumar, Dhanya;
Jankovic, Joseph

Publication type:

Article

Pharmacotherapy for Fragile X Syndrome: Progress to Date.

Published in:

Drugs, 2016, v. 76, n. 4, p. 431, doi. 10.1007/s40265-016-0542-y

By:

Davenport, Matthew;
Schaefer, Tori;
Friedmann, Katherine;
Fitzpatrick, Sarah;
Erickson, Craig

Publication type:

Article

Deciphering Riluzole: Illuminating Unexplored Avenues in Cancer Treatment through Mechanistic and Clinical Insights.

Published in:

Journal of Advanced Scientific Research, 2025, v. 16, n. 3, p. 38, doi. 10.55218/JASR.2025160307

By:

Aalam, Zubair;
Chaudhary, Anurag;
Kumar, Nitin;
Agarwal, Garima;
Ali, Hasan;
Goel, Radha;
Akbar, Md.

Publication type:

Article

Actions of Riluzole on Glast and GLT<sub>1</sub> Transporters in Rat Migraine Model.

Published in:

Indian Journal of Public Health Research & Development, 2020, v. 11, n. 2, p. 758, doi. 10.37506/v11/i2/2020/ijphrd/194900

By:

Jeevapriya, T.;
Archana, R.;
Raghunath, Gunapriya;
Sankaran, P. K.

Publication type:

Article

Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins.

Published in:

Pharmaceutics, 2024, v. 16, n. 6, p. 757, doi. 10.3390/pharmaceutics16060757

By:

Volkova, Tatyana;
Simonova, Olga;
Perlovich, German

Publication type:

Article

N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis.

Published in:

Pharmaceutics, 2023, v. 15, n. 11, p. 2638, doi. 10.3390/pharmaceutics15112638

By:

Kim, Jaejeong;
Kang, Changyu;
Yoo, Jin-Wook;
Yoon, In-Soo;
Jung, Yunjin

Publication type:

Article

An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists.

Published in:

Pharmaceutics, 2023, v. 15, n. 7, p. 2006, doi. 10.3390/pharmaceutics15072006

By:

Citraro, Rita;
Bosco, Francesca;
Di Gennaro, Gianfranco;
Tallarico, Martina;
Guarnieri, Lorenza;
Gallelli, Luca;
Rania, Vincenzo;
Siniscalchi, Antonio;
De Sarro, Giovambattista;
Leo, Antonio

Publication type:

Article

Supramolecular Organization in Salts of Riluzole with Dihydroxybenzoic Acids—The Key Role of the Mutual Arrangement of OH Groups.

Published in:

Pharmaceutics, 2023, v. 15, n. 3, p. 878, doi. 10.3390/pharmaceutics15030878

By:

Voronin, Alexander P.;
Surov, Artem O.;
Churakov, Andrei V.;
Vener, Mikhail V.

Publication type:

Article

Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain.

Published in:

Pharmaceutics, 2022, v. 14, n. 1, p. 185, doi. 10.3390/pharmaceutics14010185

By:

Teixeira, Maria Inês;
Lopes, Carla Martins;
Gonçalves, Hugo;
Catita, José;
Silva, Ana Margarida;
Rodrigues, Francisca;
Amaral, Maria Helena;
Costa, Paulo C.

Publication type:

Article

Riluzole, a Derivative of Benzothiazole as a Potential Anti-Amoebic Agent against Entamoeba histolytica.

Published in:

Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 896, doi. 10.3390/ph16060896

By:

Velásquez-Torres, Maritza;
Trujillo-Ferrara, José Guadalupe;
Godínez-Victoria, Marycarmen;
Jarillo-Luna, Rosa Adriana;
Tsutsumi, Víctor;
Sánchez-Monroy, Virginia;
Posadas-Mondragón, Araceli;
Cuevas-Hernández, Roberto Issac;
Santiago-Cruz, José Angel;
Pacheco-Yépez, Judith

Publication type:

Article

Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study.

Published in:

Psychiatry & Clinical Neurosciences, 2016, v. 70, n. 8, p. 332, doi. 10.1111/pcn.12394

By:

Emamzadehfard, Sahra;
Kamaloo, Atefeh;
Paydary, Koosha;
Ahmadipour, Ahmad;
Zeinoddini, Arefeh;
Ghaleiha, Ali;
Mohammadinejad, Payam;
Zeinoddini, Atefeh;
Akhondzadeh, Shahin

Publication type:

Article

Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer.

Published in:

Frontiers in Molecular Neuroscience, 2022, v. 15, p. 1, doi. 10.3389/fnmol.2022.1023286

By:

Khatoon, Fatima;
Haque, Shafiul;
Hashem, Anwar;
Mahmoud, Ahmad;
Tashkandi, Hanaa;
Mathkor, Darin;
Harakeh, Steve;
Alghamdi, Badra;
Kumar, Vijay

Publication type:

Article

Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data.

Published in:

Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03057-5

By:

Cai, Ruifen;
Yang, Juan;
Wu, Lijuan;
Liu, Yixiao;
Wang, Xinrui;
Zheng, Qingshan;
Li, Lujin

Publication type:

Article